Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tonix Pharm Holdings
(NQ:
TNXP
)
0.1313
+0.0002 (+0.15%)
Streaming Delayed Price
Updated: 10:27 AM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tonix Pharm Holdings
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
January 24, 2023
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
Via
News Direct
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
Via
Benzinga
Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?
December 12, 2022
TNXP stock traders are in a bidding war today as Tonix announces a possible game-changer in Covid-19 treatment methodologies.
Via
InvestorPlace
Recap: Tonix Pharmaceuticals Q3 Earnings
November 07, 2022
Tonix Pharmaceuticals (NASDAQ:TNXP) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Crude Oil Rises Sharply; Adicet Bio Shares Plunge
December 12, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday
Via
Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
Why Is Reborn Coffee (REBN) Stock Up 34% Today?
December 12, 2022
Reborn Coffee (REBN) stock is heating up on Monday as investors take note of the California coffee company's shares with heavy trading.
Via
InvestorPlace
Why Is Harpoon Therapeutics (HARP) Stock Up 100%+ Today?
December 12, 2022
Harpoon Therapeutics (HARP) stock is taking off on Monday following the release of updated results from its myeloma drug candidate.
Via
InvestorPlace
Why Tonix Pharmaceuticals Stock Is Rocketing Higher Today
December 12, 2022
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading higher Monday after the company announced the exclusive license of potential therapeutic or preventative humanized anti-SARS-CoV-2
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 12, 2022
Via
Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
November 16, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via
Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
November 03, 2022
Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases...
Via
Benzinga
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll...
Via
PressReach
Topics
Cannabis
Exposures
Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...
Via
FinancialNewsMedia
Topics
Cannabis
Exposures
Cannabis
New Ways To Treat Long Covid Might Be Here Sooner Than Thought
September 20, 2022
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure...
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
Via
Benzinga
Psychedelics Use Among Young Adults Reaches All-Time High
September 01, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,...
Via
FinancialNewsMedia
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
August 26, 2022
Via
Benzinga
Looking Into Tonix Pharmaceuticals's Recent Short Interest
August 23, 2022
Tonix Pharmaceuticals's (NASDAQ:TNXP) short percent of float has risen 204.49% since its last report. The company recently reported that it has 2.36 million shares sold short,...
Via
Benzinga
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
August 23, 2022
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
Via
Benzinga
Tonix Pharmaceuticals Commences Mid-Stage Long COVID Study, Sees Interim Report In H1 2023
August 22, 2022
Tonix Pharmaceuticals (NASDAQ: TNXP) has initiated patient enrolment in the Phase 2 PREVAIL study of TNX-102 SL for patients with Long COVID syndrome (Long COVID).
Via
Benzinga
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
August 19, 2022
Via
Benzinga
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
August 18, 2022
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.
Via
Benzinga
WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant
August 18, 2022
Via
Benzinga
A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring
August 17, 2022
Blue Water Vaccines Inc (NASDAQ: BWV)
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.